| Schedule of financial information |
| | 2026 $ | | | 2025 $ | | | | | | | | | Current assets | | | 21,060 | | | | 34,157 | | Non-current assets | | | – | | | | – | | Current liabilities | | | (14,547,212 | ) | | | (14,366,399 | ) | Non-current liabilities | | | (27,174 | ) | | | – | | | | | | | | | | | Net liabilities | | | (14,553,326 | ) | | | (14,366,399 | ) | | | | | | | | | | Net liabilities attributable to NCI | | | (1,329,708 | ) | | | (1,309,508 | ) |
| | January 31, 2026 $ | | | January 31, 2025 $ | | | January 31, 2024 $ | | | | | | | | | | | | Revenue | | | – | | | | – | | | | – | | | | | | | | | | | | | | | Net loss | | | (226,776 | ) | | | (1,604,168 | ) | | | (193,317 | ) | Other comprehensive income (loss) | | | 5,693 | | | | 1 | | | | (5,503 | ) | | | | | | | | | | | | | | Total comprehensive loss | | | (221,083 | ) | | | (1,604,167 | ) | | | (198,820 | ) | | | | | | | | | | | | | | Net loss attributable to NCI | | | (17,426 | ) | | | (101,596 | ) | | | (9,478 | ) | | | | | | | | | | | | | | Net comprehensive gain (loss) attributable to NCI | | | 276 | | | | (18 | ) | | | (329 | ) |
| | January 31, 2026 $ | | | January 31, 2025 $ | | | January 31, 2024 $ | | | | | | | | | | | | Cash flows provided by (used in) operating activities | | | 1,377 | | | | (2,046 | ) | | | 3,379 | | Cash flows provided by investing activities | | | – | | | | – | | | | – | | Cash flows (used in) provided by financing activities | | | (450 | ) | | | 1,849 | | | | – | | Effects of exchange rate changes on cash | | | 1 | | | | 1 | | | | (43 | ) | | | | | | | | | | | | | | Net (decrease) increase in cash | | | 928 | | | | (196 | ) | | | 3,336 | | | | | | | | | | | | | | | Dividends paid to NCI during the year | | | – | | | | – | | | | – | |
|